Abemaciclib (trade names Verzenio, Verzenios and Ramiven) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK
inhibitor selective for CDK4 and CDK6.|
Metastatic breast cancer only
Contact Details below.
Email: dillandday@dnmx.org
Wickr Id : dillandday
WhatsApp me ….https://wa.link/9djtfd
Call/text : +1(541) 933-0149